Tanhente, Aires J.

HRN: 18-13-41  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2023
CEFTRIAXONE 1G (VIAL)
09/02/2023
09/09/2023
IV
650
Q12
Pcap-C
Waiting Final Action 
09/02/2023
BENZYL PENICILLIN 1MU (VIAL)
09/02/2023
09/09/2023
IV
700,000units
Q6
PCAP C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: